Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The established chronic kidney disease (CKD) progression end point of end-stage renal disease (ESRD) or a doubling of serum creatinine concentration (corresponding to a change in estimated glomerular filtration rate [GFR] of −57% or greater) is a late event.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): JAMA

Title: JAMA

Publisher: American Medical Association (AMA)

ISSN (Electronic): 1538-3598

ISSN (Print): 0098-7484

Publication date (Electronic): Jun 25 2014

Volume: 311

Issue: 24

Affiliations

[1 ] Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA (J Coresh, K Matsushita, Y Sang, SH Ballew); Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada (TC Turin); Johns Hopkins Medical Institutions, Baltimore, MD, 21205 (LJ Appel); The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia (H Arima); Department of Nephrology and Transplantation, Royal Prince Alfred Hospital, Sydney, NSW, Australia and Sydney Medical School, University of Sydney, Sydney, NSW, Australia (SJ Chadban); Department of Medicine, University of Salerno, Salerno, Italy (M Cirillo); BC Provincial Renal Agency, Vancouver, Canada (O Djurdjev); Nephrology Department, Geisinger Medical Center, Danville, PA, USA (JA Green); Department of Internal Medicine IV-Nephrology and Hypertension, Saarland University Medical Center, D-66421 Homburg, Germany (GH Heine); Division of Nephrology at Tufts Medical Center, Boston, MA 02111, USA (LA Inker, AS Levey); Department of Health and Welfare, Ibaraki Prefectural Office, Mito, Japan (F Irie); Minneapolis VA Health Care System and Department of Medicine, University of Minnesota, Minneapolis, MN, USA (A Ishani); University of California San Diego, San Diego, CA, USA (JH Ix); Memphis Veterans Affairs Medical Center and University of Tennessee Health Science Center, Memphis, TN, USA (CP Kovesdy); Division of Applied Health Sciences, University of Aberdeen, and NHS Grampian, Foresterhill, Aberdeen, UK (A Marks); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan, Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan, and Department of Health Science, Shiga University of Medical Science, Setatuskinowa, Otsu, Japan (T Ohkubo); Medical Informatics Department, Maccabi Healthcare Services, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (V Shalev); Department of Family Medicine and Population Health, Virginia Commonwealth University, School of Medicine, 830 E. Main Street, P.O. Box 980212, Richmond, VA 23298-0212 (A Shankar); China Medical University Hospital, Taichung, Taiwan and Institute of Population Health Science, National Health Research Institutes, Zhunan, Taiwan (CP Wen); Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands (PE de Jong, RT Gansevoort); Dialysis Unit, University Hospital of The Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan (K Iseki); Inserm U1018, CESP Center for Research in Epidemiology and Population Health, Villejuif, France and UMRS 1018, Paris-Sud University, Villejuif, France (B Stengel).

Article

Mid ID: NIHMS608574

DOI: 10.1001/jama.2014.6634

PMC ID: 4172342

PubMed ID: 24892770

SO-VID: 94ec27cf-2b98-4f75-a536-209f91b06ad4

History

Data availability:

Comments

Comment on this article

scite_

Cited by 358

See all cited by

- Version 1
- Version 1